Clinical Trial Update: Prevention of Pelvic Lymphocele by Floseal During Pelvic Lymphadenectomy for Gynecologic Cancer [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the use of Floseal to prevent pelvic lymphocele after pelvic lymphadenectomy in gynecologic cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gynecologic Cancer

Drugs mentioned

• Floseal

Snippet

Sponsor: Ewha Womans University Mokdong Hospital | Conditions: Gynecologic Cancer | Phase 3 | Status: UNKNOWN